arrow
V

Vincent Chung

city of hope
H指数:39
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

B7-H4‒directed antibody-drug conjugate AZD8205 (puxitatug samrotecan) in patients with advanced/metastatic solid tumors: the Phase 1/2a (BLUESTAR), first-in-human study

B7-H4靶向抗体药物偶联物AZD8205(puxitatug samrotecan)在晚期/转移性实体瘤患者中的I/IIa期(BLUESTAR)首次人体研究

2026-10-300
OAAI
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic cancer: the randomized phase 2 AMPLIFY-7P trial

淋巴结靶向、mKRAS特异性的两亲性疫苗在胰腺癌中的研究:AMPLIFY-7P随机II期试验

2026-10-230
OAAI
Letter to the Editor: further reply to Kahl et al. regarding ‘NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial’

致编辑的信:关于“NALIRIFOX与 nab-paclitaxel 和 gemcitabine 在老年初治转移性胰腺癌患者中的比较:关键性 NAPOLI 3 试验的亚组分析”的进一步回复给 Kahl 等人

2026-10-090
OAAI
A phase 1 study of orally administered 5-fluoro-2’-deoxycytidine with tetrahydrouridine in patients with refractory solid tumors

一项关于口服给予5-氟-2’-脱氧胞苷与四氢尿嘧啶联合治疗难治性实体瘤的1期研究

2025-12-220
OAAI
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results

淋巴结靶向、mKRAS特异性的两亲性疫苗在胰腺癌和结直肠癌中的研究:AMPLIFY-201试验1期最终结果

2025-08-110
OAAI
Therapeutic Targeting of Oncogene-Induced Transcription-Replication Conflicts in Pancreatic Ductal Adenocarcinoma

靶向癌基因诱导的转录-复制冲突在胰导管腺癌中的治疗应用

2025-04-080
OAAI
Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
2025-02-010
PRE
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial

恩替诺特、nivolumab和ipilimumab治疗晚期HER2-negative乳腺癌的Ib期临床试验

2024-02-147
PRE
T cell responses and clinical outcomes in pancreatic and colorectal cancer patients with minimal residual disease in AMPLIFY-201, a phase 1 trial of a first-in-class amphiphile lymph node targeted mutant KRAS vaccine
2024-01-160
PRE
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial

胰腺癌和结直肠癌的淋巴结靶向,mKRAS特异性两亲疫苗: 1期扩增201试验

2024-01-0939
OAAI
Small molecule targeting of transcription-replication conflict for selective chemotherapy

选择性化疗的转录-复制冲突小分子靶向研究

2023-10-0119
OAAI
Ampullary Adenocarcinoma, Version 1.2023
2023-07-0123
OA